Richard F Schlenk

Subcutaneous Alemtuzumab in Fludarabine-Refractory Chronic Lymphocytic Leukemia: Clinical Results and Prognostic Marker Analyses From the CLL2H Study of the German Chronic Lymphocytic Leukemia Study Group

Stephan Stilgenbauer, Thorsten Zenz, Dirk Winkler et al. · Journal of Clinical Oncology · 2009 · 270 citations · Full text

Medicine, Oncology, Pharmacology +17

Additional Genetic High-Risk Features Such As 11q Deletion, 17p Deletion, and <i>V3-21</i> Usage Characterize Discordance of ZAP-70 and <i>VH</i> Mutation Status in Chronic Lymphocytic Leukemia

Alexander Kröber, Johannes Bloehdorn, Sebastian Häfner et al. · Journal of Clinical Oncology · 2006 · 193 citations · Full text

Medicine, Hematology, Oncology +15

Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

Richard F Schlenk, Stefan Fröhling, Frank Hartmann et al. · Leukemia · 2004 · 170 citations

Medicine, Hematology, Oncology +5

Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients

Michela Tassara, Konstanze Döhner, Peter Brossart et al. · Blood · 2014 · 79 citations · Full text

Medicine, Oncology, Pharmacology +12

A Face-Aging App for Smoking Cessation in a Waiting Room Setting: Pilot Study in an HIV Outpatient Clinic

Titus J. Brinker, Christian Martin Brieske, Joachim Klode et al. · Journal of Medical Internet Research · 2018 · 23 citations · Full text

Public Health, Health Behavior, Health Promotion +17